- All sections
- C - Chemistry; metallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/20 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Patent holdings for IPC class C07C 235/20
Total number of patents in this class: 142
10-year publication summary
10
|
10
|
11
|
14
|
8
|
17
|
10
|
6
|
15
|
4
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Corsair Pharma, Inc. | 35 |
11 |
The Regents of the University of California | 18943 |
10 |
Insmed Incorporated | 207 |
7 |
Autobahn Therapeutics, Inc. | 41 |
7 |
Theravance Biopharma R&D IP, LLC | 550 |
5 |
Oregon Health & Science University | 746 |
4 |
Senomyx, Inc. | 93 |
4 |
Firmenich Incorporated | 124 |
4 |
Envista | 4 |
4 |
BioTheryX, Inc. | 100 |
3 |
Trillium Therapeutics Inc. | 30 |
3 |
Cheminova A/S | 172 |
3 |
Apa- Advanced Technologies Ltd. | 4 |
3 |
BASF SE | 19740 |
2 |
AstraZeneca AB | 3042 |
2 |
FUJIFILM Corporation | 27102 |
2 |
Glaxosmithkline Intellectual Property Development Limited | 723 |
2 |
The United States of America as represented by the Secretary of the Navy | 2734 |
2 |
Aurimmed Pharma, Inc. | 6 |
2 |
ChemoCentryx, Inc. | 400 |
2 |
Other owners | 60 |